Cargando…
Gold nanotheranostics: future emblem of cancer nanomedicine
Cancer nanotheranostics aims at providing alternative approaches to traditional cancer diagnostics and therapies. In this context, plasmonic nanostructures especially gold nanostructures are intensely explored due to their tunable shape, size and surface plasmon resonance (SPR), better photothermal...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561130/ https://www.ncbi.nlm.nih.gov/pubmed/34737836 http://dx.doi.org/10.1177/18495435211053945 |
_version_ | 1784593065291284480 |
---|---|
author | Navyatha, Bankuru Nara, Seema |
author_facet | Navyatha, Bankuru Nara, Seema |
author_sort | Navyatha, Bankuru |
collection | PubMed |
description | Cancer nanotheranostics aims at providing alternative approaches to traditional cancer diagnostics and therapies. In this context, plasmonic nanostructures especially gold nanostructures are intensely explored due to their tunable shape, size and surface plasmon resonance (SPR), better photothermal therapy (PTT) and photodynamic therapy (PDT) ability, effective contrast enhancing ability in Magnetic Resonance imaging (MRI) and Computed Tomography (CT) scan. Despite rapid breakthroughs in gold nanostructures based theranostics of cancer, the translation of gold nanostructures from bench side to human applications is still questionable. The major obstacles that have been facing by nanotheranostics are specific targeting, poor resolution and photoinstability during PTT etc. In this regard, various encouraging studies have been carried out recently to overcome few of these obstacles. Use of gold nanocomposites also overcomes the limitations of gold nanostructure probes and emerged as good nanotheranostic probe. Hence, the present article discusses the advances in gold nanostructures based cancer theranostics and mainly emphasizes on the importance of gold nanocomposites which have been designed to decipher the past questions and limitations of in vivo gold nanotheranostics. |
format | Online Article Text |
id | pubmed-8561130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-85611302021-11-03 Gold nanotheranostics: future emblem of cancer nanomedicine Navyatha, Bankuru Nara, Seema Nanobiomedicine (Rij) Short Communication Cancer nanotheranostics aims at providing alternative approaches to traditional cancer diagnostics and therapies. In this context, plasmonic nanostructures especially gold nanostructures are intensely explored due to their tunable shape, size and surface plasmon resonance (SPR), better photothermal therapy (PTT) and photodynamic therapy (PDT) ability, effective contrast enhancing ability in Magnetic Resonance imaging (MRI) and Computed Tomography (CT) scan. Despite rapid breakthroughs in gold nanostructures based theranostics of cancer, the translation of gold nanostructures from bench side to human applications is still questionable. The major obstacles that have been facing by nanotheranostics are specific targeting, poor resolution and photoinstability during PTT etc. In this regard, various encouraging studies have been carried out recently to overcome few of these obstacles. Use of gold nanocomposites also overcomes the limitations of gold nanostructure probes and emerged as good nanotheranostic probe. Hence, the present article discusses the advances in gold nanostructures based cancer theranostics and mainly emphasizes on the importance of gold nanocomposites which have been designed to decipher the past questions and limitations of in vivo gold nanotheranostics. SAGE Publications 2021-10-26 /pmc/articles/PMC8561130/ /pubmed/34737836 http://dx.doi.org/10.1177/18495435211053945 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Short Communication Navyatha, Bankuru Nara, Seema Gold nanotheranostics: future emblem of cancer nanomedicine |
title | Gold nanotheranostics: future emblem of cancer
nanomedicine |
title_full | Gold nanotheranostics: future emblem of cancer
nanomedicine |
title_fullStr | Gold nanotheranostics: future emblem of cancer
nanomedicine |
title_full_unstemmed | Gold nanotheranostics: future emblem of cancer
nanomedicine |
title_short | Gold nanotheranostics: future emblem of cancer
nanomedicine |
title_sort | gold nanotheranostics: future emblem of cancer
nanomedicine |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561130/ https://www.ncbi.nlm.nih.gov/pubmed/34737836 http://dx.doi.org/10.1177/18495435211053945 |
work_keys_str_mv | AT navyathabankuru goldnanotheranosticsfutureemblemofcancernanomedicine AT naraseema goldnanotheranosticsfutureemblemofcancernanomedicine |